The investigation of the ensemble of the EVs named the “vesiculome” in patients suffering from brain tumors might possibly enrich science with unique insights such as the elucidation of oncogenic-triggered mutations and medication-resistance-correlated mutations, e.g., EGFR mutations, the unraveling of oncogenic pathways, the classification of disorder subgroups and molecular signatures. Here, EGFR is linked to brain neoplasm.